Artios Pharma Ltd., a new company focused on developing novel cancer treatments targeting DNA damage response, has been launched with a £25 million series A financing led by SV Life Sciences.
DNA damage response is a mechanism through which cells repair damaged DNA. However, research suggests tumors manipulate this ability, which...





